Skip to main content

Table 3 Diagnoses of obstructive airway diseases among subjects dispensed each R03 drug class (N (%))

From: Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland

 

ICS

LTRA

LABA

LAMA

SABA

SAMA

Asthma (n = 495)

464 (70.1)

91 (78.4)

268 (67.5)

20 (27)

309 (60.2)

4 (40)

Asthma and COPD (n = 46)

45 (6.8)

4 (3.4)

34 (8.6)

27 (36.5)

34 (6.6)

1 (10)

COPD (n = 41)

28 (4.2)

1 (0.9)

29 (7.3)

21 (28.4)

24 (4.7)

2 (20)

No obstructive airway diseases (n = 221)

125 (18.9)

20 (17.2)

66 (16.6)

6 (8.1)

146 (28.5)

3 (30)

  1. ICS inhaled corticosteroid, LABA long-acting beta-agonist, LAMA long-acting muscarinic antagonist, LTRA leukotriene receptor antagonist, OCS oral corticosteroid, SABA short-acting beta-agonist, SAMA short-acting muscarinic antagonist